Milner Institute hosts Cambridge–Oxford BioVenture Showcase, spotlighting high-potential biotech startups
On 22 January, we were delighted to host the Cambridge–Oxford BioVenture Showcase, bringing together innovators, early‑stage founders, researchers, investors, and industry partners from the Cambridge-Oxford corridor. The showcase created a dynamic forum for...
Milner Therapeutics Institute kickstarts 2026 with business-to-business event for affiliates
Last week, the Milner Institute welcomed more than 45 of its affiliated companies to a business-to-business networking event on the Cambridge Biomedical Campus. The event brought together start-ups from the Milner Bio-incubator and beyond, biotech, services and CRO...
Cathy Tralau-Stewart discusses strengthening UK therapeutic translation in Drug Discovery World
We’re delighted that our Executive Director, Professor Cathy Tralau-Stewart, has continued her thought leadership work with Drug Discovery World, with a timely article on “The role of universities and industry in driving translation of therapeutics: the need for a new...
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
We are thrilled to announce that the Functional Genomics Screening Laboratory (FGSL) has been awarded an OBN Award in the Most Impactful Industry Collaboration category. This recognises the pioneering work taking place in the FGSL — a collaboration between the Milner...